QA: Blueprint Medicines Corp in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001597264_2023_Blueprint_Medicines_Corp.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001597264, Blueprint Medicines Corp

  xvar xval
0 AssetsCurrent 1,046,651,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 33,344,000
3 remainder_Assets 269,907,000
4 LiabilitiesCurrent 183,234,000
5 LiabilitiesNoncurrent 116,714,000
6 remainder_Liabilities 535,277,000
7 CostOfGoodsAndServicesSold 17,810,863
8 SellingGeneralAndAdministrativeExpense 438,588,567
9 ResearchAndDevelopmentExpense 495,292,355
10 remainder_Expenses 16,903,732
11 remainder_Revenues 195,930,933
12 remainder_NetIncome -77,722,278
13 remainder_ComprehensiveNetIncome 1,067,362
  yvar yval
0 Assets 1,349,902,000
1 Liabilities 835,225,000
2 Expenses 968,595,517
3 Revenues 195,930,933
4 StockholdersEquity 514,677,000
5 NetIncome -850,386,862
6 ComprehensiveNetIncome -849,853,181
7 BaseVar 1,714,221,545
8 EconomicCapitalRatiobeforeLimitedLiability 0.249
9 EconomicCapitalRatio 1.65

Edgar->Model Mapping

Feature Distribution

Change over Time